| Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income … K Stenberg, O Hanssen, TTT Edejer, M Bertram, C Brindley, A Meshreky, ... The Lancet Global Health 5 (9), e875-e887, 2017 | 517 | 2017 |
| On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review D Cameron, J Ubels, F Norström Global health action 11 (1), 1447828, 2018 | 286 | 2018 |
| Cost-effectiveness analysis of stereotactic ablative body radiotherapy for the treatment of oligometastatic tumors versus standard of care AJN Raymakers, D Cameron, S Tyldesley, DA Regier Current Oncology 28 (3), 1857-1866, 2021 | 9 | 2021 |
| Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis AJN Raymakers, S Costa, D Cameron, DA Regier BMC cancer 20, 1-9, 2020 | 9 | 2020 |
| Cost-effectiveness of brexucabtagene autoleucel versus best supportive care for the treatment of relapsed/refractory mantle cell lymphoma following treatment with a Bruton’s … G Ball, C Lemieux, D Cameron, MD Seftel Current Oncology 29 (3), 2021-2045, 2022 | 8 | 2022 |
| Cost-Effectiveness of Brexucabtagene Autoleucel Versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma Following Treatment with a Bruton’s … M Seftel, C Lemieux, D Cameron, G Ball 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | | 2022 |
| Readiness of Healthcare Systems to Generate Real-World Evidence: Reliability of CT Radiographic End Points for Evaluation of First-Line Systemic Treatment C Ho, B Chan, D Cameron, A Shokoohi, DA Regier, H Lim JCO Oncology Practice 17 (12), e1923-e1929, 2021 | | 2021 |
